Journal
JOURNAL OF NEUROSCIENCE RESEARCH
Volume 95, Issue 11, Pages 2217-2235Publisher
WILEY
DOI: 10.1002/jnr.24064
Keywords
Alzheimer's disease; Parkinson's disease; epilepsy; energy metabolism; glucose utilization; glycolysis; insulin resistance; neuro-inflammation; oxidative stress
Categories
Funding
- French National Research Agency METANEX grant [ANR-2010-BLAN-1443-01]
- Alzheimer's Association [NESAD-12-242486]
Ask authors/readers for more resources
Hypometabolism, characterized by decreased brain glucose consumption, is a common feature of many neurodegenerative diseases. Initial hypometabolic brain state, created by characteristic risk factors, may predispose the brain to acquired epilepsy and sporadic Alzheimer's and Parkinson's diseases, which are the focus of this review. Analysis of available data suggests that deficient glucose metabolism is likely a primary initiating factor for these diseases, and that resulting neuronal dysfunction further promotes the metabolic imbalance, establishing an effective positive feedback loop and a downward spiral of disease progression. Therefore, metabolic correction leading to the normalization of abnormalities in glucose metabolism may be an efficient tool to treat the neurological disorders by counteracting their primary pathological mechanisms. Published and preliminary experimental results on this approach for treating Alzheimer's disease and epilepsy models support the efficacy of metabolic correction, confirming the highly promising nature of the strategy. (C) 2017 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available